Services
Gwathmey Preclinical Testing Services, Inc. provides expert outsourced preclinical services in order to help biotech and pharmaceutical companies prove that promising compounds, drugs, or biologics are viable in the marketplace, while meeting essential safety standards. The company provides timely, reliable and consistent test data required in today's drug development environment.
Gwathmey Preclinical Testing Services relieves clients of the burden of developing unique in-house capabilities to design and test individual drugs for specific disease states. We provide our clients with necessary in vivo preclinical testing services with relevant expertise, in-house permits, and requisite technologies.
The Gwathmey team works closely with clients to translate ideas into appropriate designs for optimal experimental success, through a disciplined approach and comprehensive services.
Gwathmey Preclinical Testing Services offerings include:
- Consulting
- Pharmacokinetic Studies
- Efficacy Services
- Early Discovery Toxicology Services
- Cardiac Safety Screening
- Specialty Services: Cardionomics™